Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/9/25 19:18 | 5/7/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Lamy Patrick | CA | O | SVP,Comm | 6 | S.d | -744 | 45.09 | 0 | -16 | 34 | D | |||||||||||||||
5/8/25 19:34 | 5/6/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Rolph Timothy | CA | O | Chief Sc | 12 | S.d | -4,758 | 47.50 | 0 | -100 | 198 | D | |||||||||||||||
4/16/25 18:00 | 4/15/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Yale Catriona | CA | O | Chief De | 20 | S.dm | -10,938 | 42.40 | 0 | -258 | 96 | D | |||||||||||||||
4/11/25 18:00 | 4/10/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | 13 | S.dm | -15,722 | 35.64 | 0 | -441 | 716 | D | |||||||||||||||
3/14/25 20:33 | 3/12/25 | AKRO | Health | Drug | Pharmaceutical Preparations | Young Jonathan | CA | O | COO | 19 | S.d | -7,500 | 33.64 | 0 | -223 | 587 | D | |||||||||||||||
3/14/25 20:24 | 3/12/25 | AKRO | Health | Drug | Pharmaceutical Preparations | White William Richard | CA | O | CFO | 8 | S.dm | -8,234 | 27.20 | 0 | -303 | 62 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |